JP2020516613A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516613A5 JP2020516613A5 JP2019554924A JP2019554924A JP2020516613A5 JP 2020516613 A5 JP2020516613 A5 JP 2020516613A5 JP 2019554924 A JP2019554924 A JP 2019554924A JP 2019554924 A JP2019554924 A JP 2019554924A JP 2020516613 A5 JP2020516613 A5 JP 2020516613A5
- Authority
- JP
- Japan
- Prior art keywords
- nhco
- groups
- antibody
- aspects
- nhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023066568A JP2023100679A (ja) | 2017-04-07 | 2023-04-14 | 新規化合物及びそれらの治療上の使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1705686.2 | 2017-04-07 | ||
| GBGB1705686.2A GB201705686D0 (en) | 2017-04-07 | 2017-04-07 | Novel compounds and therapeutic uses thereof |
| PCT/GB2018/050928 WO2018185495A1 (en) | 2017-04-07 | 2018-04-06 | Novel compounds and therapeutic uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023066568A Division JP2023100679A (ja) | 2017-04-07 | 2023-04-14 | 新規化合物及びそれらの治療上の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516613A JP2020516613A (ja) | 2020-06-11 |
| JP2020516613A5 true JP2020516613A5 (https=) | 2021-04-30 |
| JP7695773B2 JP7695773B2 (ja) | 2025-06-19 |
Family
ID=58744828
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019554924A Active JP7695773B2 (ja) | 2017-04-07 | 2018-04-06 | 新規化合物及びそれらの治療上の使用 |
| JP2023066568A Pending JP2023100679A (ja) | 2017-04-07 | 2023-04-14 | 新規化合物及びそれらの治療上の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023066568A Pending JP2023100679A (ja) | 2017-04-07 | 2023-04-14 | 新規化合物及びそれらの治療上の使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11766483B2 (https=) |
| EP (1) | EP3606561B1 (https=) |
| JP (2) | JP7695773B2 (https=) |
| KR (1) | KR102646581B1 (https=) |
| CN (1) | CN110753558B (https=) |
| AU (1) | AU2018248706B2 (https=) |
| CA (1) | CA3059018A1 (https=) |
| ES (1) | ES2954294T3 (https=) |
| GB (1) | GB201705686D0 (https=) |
| IL (1) | IL270460B2 (https=) |
| WO (1) | WO2018185495A1 (https=) |
| ZA (1) | ZA201906580B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201816553D0 (en) | 2018-10-10 | 2018-11-28 | Centauri Therapeutics Ltd | Novel compounds and therapeutic uses thereof |
| EP4434548A1 (en) | 2021-11-15 | 2024-09-25 | Systimmune, Inc. | Bispecific antibody-camptothecin drug conjugate and pharmaceutical use thereof |
| GB202406865D0 (en) | 2024-05-15 | 2024-06-26 | Centauri Therapeutics Ltd | Novel compounds and therapeutics uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6090381A (en) | 1997-02-11 | 2000-07-18 | Immunomedics, Inc. | Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope |
| FR2801305B1 (fr) | 1999-11-24 | 2002-12-06 | Galderma Res & Dev | Analogues de la vitamine d |
| US7645743B2 (en) * | 1999-12-22 | 2010-01-12 | Altermune, Llc | Chemically programmable immunity |
| FI20011664L (fi) | 2001-08-17 | 2003-02-18 | Carbion Oy | Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö |
| JP2005535723A (ja) | 2002-08-20 | 2005-11-24 | バイオティ セラピィーズ コープ | 腫瘍特異的オリゴ糖エピトープおよびその用途 |
| WO2006123725A1 (ja) * | 2005-05-19 | 2006-11-23 | Astellas Pharma Inc. | ピロリジン誘導体またはその塩 |
| FR2886298A1 (fr) * | 2005-05-24 | 2006-12-01 | Ifremer | Anticorps ou fragment d'anticorps couple a un agent immunogene |
| CN101374546B (zh) * | 2005-12-16 | 2016-03-23 | Ibc医药公司 | 基于免疫球蛋白的多价生物活性装配体 |
| CA2655246A1 (en) * | 2006-06-09 | 2007-12-21 | University Of Maryland, Baltimore | Glycosylation engineered antibody therapy |
| WO2009108807A1 (en) | 2008-02-26 | 2009-09-03 | The Regents Of The University Of California | Glycopeptides and methods of making and using them |
| EP2283358B1 (en) * | 2008-04-29 | 2015-04-22 | Immunexcite, Inc. | Immunomodulating compositions and methods of use thereof |
| US9079880B2 (en) * | 2010-07-07 | 2015-07-14 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
| EP2836485B1 (en) * | 2012-03-17 | 2018-01-10 | Polyphor Ag | Conformationally constrained, fully synthetic macrocyclic compounds |
| US9556167B2 (en) * | 2012-05-02 | 2017-01-31 | Yale University | TLR-agonist-conjugated antibody recruiting molecules (TLR-ARMs) |
| EP3160513B1 (en) * | 2014-06-30 | 2020-02-12 | Glykos Finland Oy | Saccharide derivative of a toxic payload and antibody conjugates thereof |
| GB201517859D0 (en) | 2015-10-08 | 2015-11-25 | Altermune Ltd | Novel compounds and therapeutic uses thereof |
| WO2018051085A1 (en) * | 2016-09-13 | 2018-03-22 | Centauri Therapeutics Limited | Novel compounds and therapeutic uses thereof |
-
2017
- 2017-04-07 GB GBGB1705686.2A patent/GB201705686D0/en not_active Ceased
-
2018
- 2018-04-06 WO PCT/GB2018/050928 patent/WO2018185495A1/en not_active Ceased
- 2018-04-06 AU AU2018248706A patent/AU2018248706B2/en active Active
- 2018-04-06 CA CA3059018A patent/CA3059018A1/en active Pending
- 2018-04-06 ES ES18717680T patent/ES2954294T3/es active Active
- 2018-04-06 JP JP2019554924A patent/JP7695773B2/ja active Active
- 2018-04-06 KR KR1020197032866A patent/KR102646581B1/ko active Active
- 2018-04-06 US US16/603,579 patent/US11766483B2/en active Active
- 2018-04-06 EP EP18717680.5A patent/EP3606561B1/en active Active
- 2018-04-06 CN CN201880037436.4A patent/CN110753558B/zh active Active
- 2018-04-08 IL IL270460A patent/IL270460B2/en unknown
-
2019
- 2019-10-07 ZA ZA2019/06580A patent/ZA201906580B/en unknown
-
2023
- 2023-04-14 JP JP2023066568A patent/JP2023100679A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2460517T3 (es) | Reducción de células b mediante el uso de moléculas de unión específica a cd37 y de unión específica a cd20 | |
| RU2421464C2 (ru) | Человеческие антитела к il-13 и их терапевтическое применение | |
| TWI436770B (zh) | 包含專一性辨識ｃｄ３８之抗體及阿糖胞苷（ｃｙｔａｒａｂｉｎｅ）之抗腫瘤組合 | |
| EP3442584B1 (en) | Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors | |
| JP2021516976A5 (https=) | ||
| JP2021515566A5 (https=) | ||
| CN109589336B (zh) | 用于t细胞免疫疗法的组合及其用途 | |
| JP2015534579A5 (https=) | ||
| JP2015534577A5 (https=) | ||
| JP2011501656A5 (https=) | ||
| RU2018139811A (ru) | Мультиспецифические антигенсвязывающие конструкции, нацеливающие иммунотерапевтические средства | |
| JP2015534578A5 (https=) | ||
| JP2018527919A5 (https=) | ||
| JP2014534806A5 (https=) | ||
| JP2017036297A (ja) | Ｃｄ３８を特異的に認識する抗体とシクロホスファミドとを含有する抗腫瘍組合せ | |
| JP2018500014A5 (https=) | ||
| JP2020500834A5 (https=) | ||
| JP2015503909A5 (https=) | ||
| TW201024310A (en) | Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine | |
| RU2013142004A (ru) | Конъюгаты "антитело-лекарственное средство" | |
| JP2019505527A5 (https=) | ||
| JP2025026572A5 (https=) | ||
| JP2018531287A5 (https=) | ||
| JP2017537082A5 (https=) | ||
| JP2017507131A5 (https=) |